DTLA Research Center, Inc is a dedicated clinical research site conducting Phase II to IV, bioequivalence clinical studies for various pharmaceutical companies. DTLARC, Inc began conducting cardiovascular clinical trials. We now conduct studies on a wide range of conditions including but not limited to: Hypertension, High Cholesterol, Type 2 Diabetes Mellitus, COPD, Asthma, Seasonal Flu, RSV, Migraine Headaches, Herpes Labialis, Obesity, Depression, Anxiety, Gout, Nocturia, Impotence, GERD, NERD, and others. Our growing patient’s database (>25,000) allows for quick study enrollment, often exceeding original enrollment goals.